All changes for the tissue brain (734)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1973
5-hmC increase in cerebrellum
Molecular
cerebellum
Mouse
—
—
DAA1
abhydrolase domain containing 14A
Molecular
brain
Human
ABHD14A
3.0% Decrease Gene Expression Level
DAA1944
Ability to acquire motor skills decreases
Psychological
brain
Mouse
—
—
DAA2
abl-interactor 2
Molecular
brain
Human
ABI2
18.0% Decrease Gene Expression Level
DAA723
Accumulation of extracellular neuritic plaques
Physiological
brain
Human
—
—
DAA722
Accumulation of neuromelanin in dopaminergic nigral neurons
Physiological
substantia nigra
Human
—
—
DAA3
actin, alpha 1, skeletal muscle
Molecular
brain
Human
ACTA1
16.0% Decrease Gene Expression Level
DAA4
actin, beta
Molecular
brain
Human
ACTB
4.0% Decrease Gene Expression Level
DAA5
actin-like 6A
Molecular
brain
Human
ACTL6A
21.0% Increase Gene Expression Level
DAA761
Activation threshold for long-term potentiation is increased
Psychological
brain
Human
—
—
DAA618
Acute rheumatic fever and chronic rheumatic heart diseases
Pathological
heart, skin, brain
Human
—
SeriesMorbidity
DAA1391
acyl-CoA synthetase short-chain family member 1
Molecular
hippocampus
Mouse
Acss1
2.0% Decrease Gene Expression Level
DAA12
adaptor-related protein complex 1, sigma 1 subunit
Molecular
brain
Human
AP1S1
12.0% Decrease Gene Expression Level
DAA6
AHNAK nucleoprotein
Molecular
brain
Human
AHNAK
13.0% Increase Gene Expression Level
DAA1247
albumin
Molecular
brain
Mouse
Alb
88.0% Increase Gene Expression Level
DAA7
aldehyde dehydrogenase 9 family, member A1
Molecular
brain
Human
ALDH9A1
10.0% Increase Gene Expression Level
DAA1967
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase
Molecular
cerebellum
Mouse
—
—
DAA1966
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase
Molecular
hippocampus
Mouse
—
—
DAA1964
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase
Molecular
cerebellum
Mouse
Alox5
—
DAA2041
Altered brain mitochondrial metabolism
Physiological
brain
Human
—
—
DAA748
Altered sleep parameters and patterns
Psychological
brain
Human
—
—
DAA615
Alzheimer's disease
Pathological
brain
Human
—
SeriesMorbidity
DAA8
angiomotin
Molecular
brain
Human
AMOT
10.0% Increase Gene Expression Level
DAA9
ankyrin 2, neuronal
Molecular
brain
Human
ANK2
20.0% Decrease Gene Expression Level
DAA1394
annexin A2
Molecular
hippocampus
Mouse
Anxa2
8.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1973 | 5-hmC increase in cerebrellum | Molecular | cerebellum | Mouse | — | — | |
DAA1 | abhydrolase domain containing 14A | Molecular | brain | Human | ABHD14A | 3.0% Decrease Gene Expression Level | |
DAA1944 | Ability to acquire motor skills decreases | Psychological | brain | Mouse | — | — | |
DAA2 | abl-interactor 2 | Molecular | brain | Human | ABI2 | 18.0% Decrease Gene Expression Level | |
DAA723 | Accumulation of extracellular neuritic plaques | Physiological | brain | Human | — | — | |
DAA722 | Accumulation of neuromelanin in dopaminergic nigral neurons | Physiological | substantia nigra | Human | — | — | |
DAA3 | actin, alpha 1, skeletal muscle | Molecular | brain | Human | ACTA1 | 16.0% Decrease Gene Expression Level | |
DAA4 | actin, beta | Molecular | brain | Human | ACTB | 4.0% Decrease Gene Expression Level | |
DAA5 | actin-like 6A | Molecular | brain | Human | ACTL6A | 21.0% Increase Gene Expression Level | |
DAA761 | Activation threshold for long-term potentiation is increased | Psychological | brain | Human | — | — | |
DAA618 | Acute rheumatic fever and chronic rheumatic heart diseases | Pathological | heart, skin, brain | Human | — | SeriesMorbidity | |
DAA1391 | acyl-CoA synthetase short-chain family member 1 | Molecular | hippocampus | Mouse | Acss1 | 2.0% Decrease Gene Expression Level | |
DAA12 | adaptor-related protein complex 1, sigma 1 subunit | Molecular | brain | Human | AP1S1 | 12.0% Decrease Gene Expression Level | |
DAA6 | AHNAK nucleoprotein | Molecular | brain | Human | AHNAK | 13.0% Increase Gene Expression Level | |
DAA1247 | albumin | Molecular | brain | Mouse | Alb | 88.0% Increase Gene Expression Level | |
DAA7 | aldehyde dehydrogenase 9 family, member A1 | Molecular | brain | Human | ALDH9A1 | 10.0% Increase Gene Expression Level | |
DAA1967 | Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase | Molecular | cerebellum | Mouse | — | — | |
DAA1966 | Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase | Molecular | hippocampus | Mouse | — | — | |
DAA1964 | Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase | Molecular | cerebellum | Mouse | Alox5 | — | |
DAA2041 | Altered brain mitochondrial metabolism | Physiological | brain | Human | — | — | |
DAA748 | Altered sleep parameters and patterns | Psychological | brain | Human | — | — | |
DAA615 | Alzheimer's disease | Pathological | brain | Human | — | SeriesMorbidity | |
DAA8 | angiomotin | Molecular | brain | Human | AMOT | 10.0% Increase Gene Expression Level | |
DAA9 | ankyrin 2, neuronal | Molecular | brain | Human | ANK2 | 20.0% Decrease Gene Expression Level | |
DAA1394 | annexin A2 | Molecular | hippocampus | Mouse | Anxa2 | 8.0% Increase Gene Expression Level |